切换至 "中华医学电子期刊资源库"
高级检索
中华普通外科学文献(电子版)

中华普通外科学文献(电子版) ›› 2019, Vol. 13 ›› Issue (04) : 327 -336. doi: 10.3877/cma.j.issn.1674-0793.2019.04.019

所属专题： 文献；

循证医学

经肛门与传统腹腔镜全系膜切除术在中低位直肠癌中可行性与安全性的Meta分析
赵葳1, 曾祥1, 殷红专2,†()   
  1. 1. 110000　沈阳，中国医科大学附属盛京医院社会服务部
    2. 110000　沈阳，中国医科大学附属盛京医院结直肠肛门病外科
  • 收稿日期:2019-02-24 出版日期:2019-08-01
  • 通信作者: 殷红专
  • 基金资助:
    辽宁省自然科学基金资助项目(201602869)

Feasibility and safety of transanal total mesorectal excision and traditional laparoscopic total mesorectal in middle-low rectal cancer: a Meta-analysis

Wei Zhao1, Xiang Zeng1, Hongzhuan Yin2,†()   

  1. 1. Social Service Department, Shengjing Hospital of China Medical University, Shenyang 110000, China
    2. Deparment of Colorectal Anus Surgery, Shengjing Hospital of China Medical University, Shenyang 110000, China
  • Received:2019-02-24 Published:2019-08-01
  • Corresponding author: Hongzhuan Yin
  • About author:
    Corresponding author: Yin Hongzhuan, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

赵葳, 曾祥, 殷红专. 经肛门与传统腹腔镜全系膜切除术在中低位直肠癌中可行性与安全性的Meta分析[J/OL]. 中华普通外科学文献(电子版), 2019, 13(04): 327-336.

Wei Zhao, Xiang Zeng, Hongzhuan Yin. Feasibility and safety of transanal total mesorectal excision and traditional laparoscopic total mesorectal in middle-low rectal cancer: a Meta-analysis[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2019, 13(04): 327-336.

目的

系统性评价经肛门全直肠系膜切除（TaTME）与腹腔镜全直肠系膜切除（LaTME）治疗中低位直肠癌的术中、术后指标，并发症及其病理学结果，分析TaTME术式可行性及安全性。

方法

通过检索Pubmed、EMBase、Cochrane Library、中国知网、万方、重庆维普国内外大型数据库，筛选2015年2月至2019年4月间发表的关于TaTME与LaTME治疗中低位直肠癌的相关文献。文献质量标准采用纽卡斯尔-渥太华量表（NOS），采用Revman 5.3软件进行Meta分析，敏感性分析异质性结果。

结果

共13篇文献1 096例患者符合纳入标准，包括TaTME组515例，LaTME组581例。与LaTME组相比，TaTME组具有高质量的CRM距离（MD=0.95，95%CI=0.61~1.29，P<0.001），低CRM阳性率（OR=0.35，95%CI=0.16~0.78，P=0.010），高质量的全直肠系膜切除（OR=2.41，95%CI=1.29~4.51，P=0.006），低中转开腹率（OR=0.20，95%CI=0.07~0.58，P=0.003），Clavien-Dindo分级3级及以上术后并发症发生率（OR=0.54，95%CI=0.32~0.92，P=0.020）、术后排尿障碍发生率低（OR=0.54，95%CI=0.31~0.94，P=0.030）及低非计划性二次入院率（OR=0.44，95%CI=0.27~0.73，P=0.001）。两组在DRM阳性率及切除距离、淋巴结清扫数量、术中失血量、手术持续时间以及总并发症、肠梗阻、吻合口瘘发生率等方面差异无统计学意义。

结论

相较于LaTME术式，TaTME治疗中低位直肠癌可以得到更高质量的标本，术后危重并发症发生率明显降低，术式可行且安全。

关键词: 直肠肿瘤, 全直肠系膜切除术, 经肛门, 腹腔镜
Objective

To systematically evaluate the intraoperative and postoperative indicators, complications and pathological results of transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LaTME) in the treatment of middle and low rectal cancer, and to analyze the feasibility and safety of TaTME.

Methods

The database both at home and abroad including Pubmed, EMBase, Cochrane Library, CNKI, Wanfang, VIP were searched between February 2015 and April 2019. All eligible studies associated with the treatment of middle and low rectal cancer with TaTME and LaTME were systematically analyzed. Newcastle-Ottawa Scale (NOS) and Revman 5.3 software were used to conduct Meta-analysis and sensitivity analysis of heterogeneous results.

Results

A total of thirteen articles including 1 096 cases met the inclusion criteria, including 515 cases in group TaTME and 581 cases in group LaTME. Compared with group LaTME, group TaTME had longer CRM distance (MD=0.95, 95%CI=0.61-1.29, P<0.001), lower CRM positive rate (OR=0.35, 95%CI=0.16-0.78, P=0.010), higher quality TME (OR=2.41, 95%CI=1.29-4.51, P=0.006), lower rate of conversion to laparotomy (OR=0.20, 95%CI=0.07-0.58, P=0.003), Clavien-Dindo grade≥3 complications (OR=0.54, 95%CI=0.32-0.92, P=0.020), incidence of postoperative urination disorders (OR=0.54, 95%CI=0.31-0.94, P=0.030) and lower unplanned secondary admission (OR=0.44, 95%CI=0.27-0.73, P=0.001). There were no significant differences in DRM positive rate, resection distance, number of lymph node dissection, intraoperative blood loss, duration of operation, incidence of total complications, incidence of intestinal obstruction and anastomotic leakage between the two groups.

Conclusion

Compared with LaTME, TaTME can obtain higher specimens quality in the treatment of middle and low rectal cancer, the incidence of serious complications after operation is significantly reduced, and the operation is feasible and safe.

Key words: Rectal neoplasms, Total mesorectal excision, Transanal, Laparoscopes
图1 文献检索筛选流程图
表1 纳入文献研究特征汇总
第一作者 研究设计 年份 国家/地区 研究例数 性别(例，男/女) 年龄(岁,Ta/La) ASA Ⅰ~Ⅱ/Ⅲ~Ⅳ BMI (Ta/La) 肿瘤距离肛缘(cm,Ta/La) 辅助放疗(例，是/否) NOS评分
合计 Ta La 合计 Ta La Ta La Ta La
Fernández-Hevia [9] C 2015 西班牙 74 37 37 46/28 24/13 22/15 64.5/69.5 30/7 25/12 23.7/25.1 NA 28/9 23/14 9
De’ Angelis [10] CM 2015 法国 64 32 32 42/22 21/11 21/11 64.91/67.16 31/1 31/1 25.19/24.53 4/3.7 27/5 23/9 8
Chen[11] C 2016 中国 150 50 100 114/36 38/12 76/24 57.3/58.3 33/17 69/31 24.2/24.6 5.8/6.7 NA NA 9
Lelong[12] C 2017 法国 72 34 38 45/27 23/11 22/16 NA 30/4 36/2 NA NA 30/4 35/3 9
Marks[13] C 2016 美国 34 17 17 NA NA NA 59/60 NA NA 26.4/25.9 NA 17/0 17/0 8
Bjoern[14] C 2018 丹麦 85 49 36 53/32 37/12 16/20 64.88/62.42 41/8 35/1 26.57/25.45 8.35/8.14 8/41 8/28 8
Perdawood[15] C 2018 丹麦 200 100 100 141/59 72/28 69/31 67.33/66.86 80/20 89/11 25.65/25.43 NA 18/82 27/73 7
Roodbeen[16] C 2018 荷兰 82 41 41 66/16 34/7 32/9 62.5/66 36/5 38/3 26.7/26.1 5/4.5 18/23 18/23 9
Chang[17] C 2018 中国 46 23 23 26/20 13/10 13/10 62.4/62.9 20/3 22/1 25.8/25.0 4.3/5.9 8/15 14/9 8
Veltcamp Helbach [18] C 2018 荷兰 54 27 27 38/16 18/9 20/7 68/62.7 25/2 25/2 27.6/26.1 NA 18/9 22/5 8
Chen[19] CM 2018 中国台湾 103 39 64 71/32 29/10 42/22 62/64 33/6 58/6 25.4/24.6 4.3/5.8 15/24 31/33 9
Mege[20] CM 2018 法国 68 34 34 46/22 23/11 23/11 58/59 33/1 32/2 25/25 NA 29/5 29/5 7
梁海峰[21] C 2019 中国 64 32 32 29/37 14/18 15/19 55.2/53.8 27/5 28/4 24.8/25.7 NA NA NA 8
图2 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术治疗中低位直肠癌环周切缘（CRM）阳性率的Meta分析
图3 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术治疗中低位直肠癌环周切缘（CRM）距离的Meta分析
图4 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术治疗中低位直肠癌远端切缘（DRM）阳性率的Meta分析
图5 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术治疗中低位直肠癌远端切缘（DRM）距离的Meta分析
图6 经经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌非计划性二次入院发生率的Meta分析
图7 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌淋巴结清扫数量的Meta分析
图8 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌术中失血量的Meta分析
图9 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌手术持续时间的Meta分析
图10 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌术后Clavien-Dindo≥3级并发症发生率的Meta分析
图11 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌术后总并发症发生率的Meta分析
图12 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌直肠系膜完全和几乎完全切除率的Meta分析
图13 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌术后肠梗阻发生率的Meta分析
图14 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌中转开腹率的Meta分析
图15 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌术后吻合口瘘发生率的Meta分析
图16 经肛门（TaTME）与传统腹腔镜（LaTME）全系膜切除术在中低位直肠癌术后排尿障碍发生率的Meta分析
[1]
Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?[J]. Br J Surg, 1982, 69(10): 613-616.
[2]
Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial[J]. Lancet Oncol, 2010, 11(7): 637-645.
[3]
Stevenson ARL, Solomon MJ, Lumley JW, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial[J]. JAMA, 2015, 314(13): 1356-1363.
[4]
Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage Ⅱ or Ⅲ rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial[J]. JAMA, 2015, 314: 1346-1355.
[5]
Rouanet P, Mourregot A, Azar CC, et al. Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis[J]. Dis Colon Rectum, 2013, 56(4): 408-415.
[6]
van der Pas MH, Haglind E, Cuesta MA, et al. Laparoscopic versus open surgery for rectal cancer (COLOR Ⅱ): short-term outcomes of a randomised, phase 3 trial[J]. Lancet Oncol, 2013, 14(3): 210-218.
[7]
Hu D, Jin P, Hu L, et al. The application of transanal total mesorectal excision for patients with middle and low rectal cancer: A systematic review and Meta-analysis[J]. Medicine (Baltimore), 2018, 97(28): e11410.
[8]
Deijen CL, Velthuis S, Tasi A, et al. COLOR Ⅲ: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer[J]. Surg Endosc, 2016, 30(8): 3210-3215.
[9]
Fernández-Hevia M, Delgado S, Castells A, et al. Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery[J]. Ann Surg, 2015, 261(2): 221-227.
[10]
De’Angelis N, Portigliotti L, Azoulay D, et al. Transanal total mesorectal excision for rectal cancer: a single center experience and systematic review of the literature[J]. Langenbecks Arch Surg, 2015, 400(8): 945-959.
[11]
Chen CC, Lai YL, Jiang JK, et al. Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation: a matched case-control study[J]. Ann Surg Oncol, 2016, 23(4): 1169-1176.
[12]
Lelong B, Meillat H, Zemmour C, et al. Short and mid-term outcomes after endoscopic transanal or laparoscopic transabdominal total mesorectal excision for low rectal cancer: a single institutional case-control study[J]. Am Coll Surg, 2017, 224(5): 917-925.
[13]
Marks JH, Montenegro GA, Salem JF, et al. Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer[J]. Tech Coloproctol, 2016, 20(7): 467-473.
[14]
Bjoern MX, Nielsen S, Perdawood SK. Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches[J]. J Gastrointest Surg, 2019 Jan 2. [Epub ahead of print]
[15]
Perdawood SK, Thinggaard BS, Bjoern MX. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries[J]. Surg Endosc, 2018, 32(5): 2312-2321.
[16]
Roodbeen SX, Penna M, Mackenzie H, et al. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes[J]. Surg Endosc, 2018 Oct 22. [Epub ahead of print]
[17]
Chang TC, Kiu KT. Transanal total mesorectal excision in lower rectal cancer: comparison of short-term outcomes with conventional laparoscopic total mesorectal excision[J]. J Laparoendosc Adv Surg Tech, 2018, 28(4): 365-369.
[18]
Veltcamp Helbach M, Koedam TWA, Knol JJ, et al. Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision[J]. Surg Endosc, 2019, 33(1): 79-87.
[19]
Chen YT, Kiu KT, Yen MH, et al. Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal excision (TME), laparoscopic TME, and open TME[J]. Asian J Surg, 2019, 42(6): 674-680.
[20]
Mege D, Hain E, Lakkis Z, et al. Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients[J]. Colorectal Dis, 2018, 20(6): O143-O151.
[21]
梁海峰，成敏敏，刘有生. 经肛门全直肠系膜切除和腹腔镜全直肠系膜切除对直肠癌的疗效对比[J/CD]. 中华普通外科学文献（电子版）, 2019, 13(2): 125-129.
[22]
Nacion AJD, Park YY, Yang SY, et al. Critical and challenging issues in the surgical management of low-lying rectal cancer[J]. Yonsei Med J, 2018, 59(6): 703-716.
[23]
Sylla P, Rattner DW, Delgado S, et al. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance[J]. Surg Endosc, 2010, 24(5): 1205-1210.
[24]
Penna M, Cunningham C, Hompes R. Transanal total mesorectal excision: why, when, and how[J]. Clin Colon Rectal Surg, 2017, 30(5): 339-345.
[25]
Rubinkiewicz M, Nowakowski M, Wierdak M, et al. Transanal total mesorectal excision for low rectal cancer: a case-matched study comparing TaTME versus standard laparoscopic TME[J]. Cancer Manag Res, 2018, 10: 5239-5245.
[26]
Penna M, Knol JJ, Tuynman JB, et al. Four anastomotic techniques following transanal total mesorectal excision (TaTME)[J]. Tech Coloproctol, 2016, 20(3): 185-191.
[27]
Penna M, Hompes R, Arnold S, et al. Transanal total mesorectal excision: international registry results of the first 720 cases[J]. Ann Surg, 2017, 266(1): 111-117.
[28]
Mizrahi I, Sands DR. Transanal total mesorectal excision for rectal cancer: a review[J]. Ann Laparosc Endosc Surg, 2017, 2: 144-151.
[29]
Tuech JJ, Karoui M, Lelong B, et al. A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy[J]. Ann Surg, 2015, 261(2): 228-233.
[30]
Sailihoglu Z, Demiroluk S, Cakmakkaya S, et al. Influence of the patient positioning on respiratory mechanics during pneumoperitoneum[J]. Middle East J Anaesthesiol, 2002, 16(5): 521-528.
[31]
Shiraishi T, Nishizawa Y, Yamamoto H, et al. Carbon dioxide embolism during transanal total mesorectal excision (taTME)[J]. Tech Coloproctol, 2018, 22(9): 735-738.
[32]
Lei P, Ruan Y, Yang X, et al. Trans-anal or trans-abdominal total mesorectal excision? A systematic review and Meta-analysis of recent comparative studies on perioperative outcomes and pathological result[J]. Int J Surg, 2018, 60: 113-119.
[33]
Ma B, Gao P, Song Y, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and Meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision[J]. BMC Cancer, 2016, 16: 380.
[34]
Xu W, Xu Z, Cheng H, et al. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A Meta-analysis[J]. Eur J Surg Oncol, 2016, 42(12): 1841-1850.
[35]
Zhang X, Gao Y, Dai X, et al. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a Meta-analysis[J]. Surg Endosc, 2019, 33(3): 972-985.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[11] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[12] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[13] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号